Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

English Funding Nod For Lilly’s Diabetes GLP-1 Mounjaro, Roche’s Cancer MAb Columvi

Sep 08 2023

• By Eliza Slawther

Close up of diverse young people show thumbs up recommending good quality service, multiethnic clients or customers — • Source: Shutterstock/fizkes

Related Content

UCB’s Bimekizumab Gets Fast-Track Funding For Severe Psoriasis In England

Aug 02 2021

EMA OKs Seven New Drugs Including First RSV Vaccine For Older Adults

Apr 27 2023

Almost 3,000 Patients Treated Under UK’s Early Access To Medicines Scheme

Jul 20 2023

EMA Probe Into Suicide Risk With Liraglutide & Semaglutide Extended To Other GLP-1 Receptor Agonists

Jul 11 2023

Can New Generation GLP-1s Overcome The Adherence Hurdle?

Jul 31 2023

Lilly Sales Swing Back As Pandemic, Loss Of Exclusivity Pressures Recede

Aug 09 2023

Related Companies

Eli Lilly and Company

Roche Holding AG

Genentech, Inc.

UCB S.A.

Additional Topics

Europe United Kingdom Cost Effectiveness Health Technology Assessment Market Access Reimbursement BioPharmaceutical Cancer Blood & Coagulation Disorders Inflammation Metabolic Disorders

More from Market Access

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window